Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Sirolimus Stents Better at Reducing Restenosis
Link ID 3287
Title Sirolimus Stents Better at Reducing Restenosis
Url http://www.medscape.com/viewarticle/570189?src=rss
Description Sirolimus-eluting stents may offer an advantage over bare-metal stents in patients with ST segment elevation myocardial infarction (STEMI), Dutch researchers report in the February 12th issue of the Journal of the American College of Cardiology. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Feb 15, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Nelarabine Active Against Indolent Leukemias
  Nelarabine alone, or particularly in combination with fludarabine, appears to be useful in the treatment of relapsed and refractory indolent leukemias, according to findings from a small phase I trial. Reuters Health Information
Category:   Articles > Pharmacists


2. Value of Chemoradiotherapy in Nonresectable Rectal Cancer Confirmed
  In nonresectable rectal cancer, the addition of chemotherapy to radiotherapy, compared with radiotherapy alone, improves local control and prolongs time to treatment failure and cancer-specific survival, results of a randomized phase III study confirm. Reuters Health Information
Category:   Articles > Pharmacists


3. High-Dose Erythropoietin Safe for Very Preterm Infants
  High-dose recombinant erythropoietin is well tolerated and can be safely given to very preterm infants, according to the results of two studies in the August issue of Pediatrics. Reuters Health Information
Category:   Articles > Pharmacists


4. Advances in Treatment for Ankylosing Spondylitis and Other Rheumatic Conditions -- Efficacy and Safe
  Dr. Alan Matsumoto reviews data from ACR 2007 on the efficacy and safety of anti-TNF therapy for ankylosing spondylitis, psoriatic arthritis, and sarcoidosis.
Medscape Rheumatology
Category:   Articles > Pharmacists


5. FDA Grants Additional Indication for Rosuvastatin
  The Food and Drug Administration has approved a new indication for rosuvastatin to slow the progression of atherosclerosis in patients with elevated cholesterol. Medscape Medical News
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS